SINOVAC BIOTECH LTD Deferred Revenue
SINOVAC BIOTECH LTD (SVA) had Deferred Revenue of $11.27 million as of 2025-12-31, per its 20-F filed 2026-06-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2026-06-05
- 2025-12-31: Deferred Revenue, Current $11.27M.
- 2024-12-31: Deferred Revenue, Current $12.21M.
- 2023-12-31: Deferred Revenue, Current $27.05M; Deferred Revenue, Current as first filed $20.13M.
- 2022-12-31: Deferred Revenue, Current $25.54M; Deferred Revenue, Current as first filed $17.95M.
| Period end | Deferred Revenue, Current | Deferred Revenue, Current as first filed |
|---|---|---|
| 2025-12-31 | $11.27M 20-F · filed 2026-06-05 | |
| 2024-12-31 | $12.21M 20-F · filed 2026-06-05 | |
| 2023-12-31 | $27.05M 20-F · filed 2026-06-05 | $20.13M 20-F · filed 2024-04-29 |
| 2022-12-31 | $25.54M 20-F · filed 2026-04-30 | $17.95M 20-F · filed 2023-05-01 |
| 2021-12-31 | $79.72M 20-F · filed 2026-04-30 | $79.94M 20-F · filed 2022-04-29 |
| 2020-12-31 | $363.79M 20-F · filed 2026-04-30 | $364.00M 20-F · filed 2021-04-22 |
| 2019-12-31 | $5.46M 20-F · filed 2021-04-22 | |
| 2018-12-31 | $2.91M 20-F · filed 2020-04-30 | |
| 2017-12-31 | $4.07M 20-F · filed 2019-04-29 | |
| 2016-12-31 | $2.77M 20-F · filed 2018-05-11 | |
| 2015-12-31 | $8.14M 20-F · filed 2017-11-22 | |
| 2014-12-31 | $5.00M 20-F · filed 2016-04-25 | |
| 2013-12-31 | $875.00K 20-F · filed 2015-04-29 | |
| 2012-12-31 | $1.38M 20-F · filed 2014-04-16 | $1.38M 20-F/A · filed 2013-05-23 |
| 2011-12-31 | $429.42K 20-F/A · filed 2013-05-23 |